Osteopontin (OPN) expression in thyroid carcinoma.
Standard
Osteopontin (OPN) expression in thyroid carcinoma. / Briese, Juliane; Cheng, Sonia; Ezzat, Shereen; Liu, Wei; Winer, Daniel; Wagener, Christoph; Bamberger, Ana Maria; Asa, Sylvia L.
in: ANTICANCER RES, Jahrgang 30, Nr. 5, 5, 2010, S. 1681-1688.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Osteopontin (OPN) expression in thyroid carcinoma.
AU - Briese, Juliane
AU - Cheng, Sonia
AU - Ezzat, Shereen
AU - Liu, Wei
AU - Winer, Daniel
AU - Wagener, Christoph
AU - Bamberger, Ana Maria
AU - Asa, Sylvia L
PY - 2010
Y1 - 2010
N2 - Osteopontin (OPN) and its interacting partner CEA-cell adhesion molecule (CEACAM1) mediate similar biological functions and have been expressed in several types of cancer. Here we investigated the prognostic significance of OPN in thyroid tumours and correlated our findings with the expression of CEACAM1.
AB - Osteopontin (OPN) and its interacting partner CEA-cell adhesion molecule (CEACAM1) mediate similar biological functions and have been expressed in several types of cancer. Here we investigated the prognostic significance of OPN in thyroid tumours and correlated our findings with the expression of CEACAM1.
M3 - SCORING: Zeitschriftenaufsatz
VL - 30
SP - 1681
EP - 1688
JO - ANTICANCER RES
JF - ANTICANCER RES
SN - 0250-7005
IS - 5
M1 - 5
ER -